TP53 and lung carcinoma: Among TP53-mutated lung cancers, AFs of TP53 mutations, including oncogenic and non-oncogenic mutations, were significantly higher in lung cancers located in segments 9 and 10, the dorsal inferior lobes, than in those located in the other segments (1 to 8) (Figure 6A, Figure S2).